SCHEMBL7222389

SCHEMBL7222389

Cc1ccc(-c2ccc3c(c2)C=C(C(=O)NC2CCN(Cc4ccccc4)CC2)CCO3)cc1

nearest known ligand 0.54

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.54
SLC6A12 P48065 1/20 0.52
SLC6A13 Q9NSD5 1/20 0.52
MCHR1 Q99705 1/20 0.52
CCR5 P51681 12/20 0.51
CHRM4 P08173 1/20 0.50
DRD4 P21917 1/20 0.49
POLB P06746 1/20 0.49
MAOB P27338 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222422 0.88 CHRM4 (0.62) ACHECCR5CHRM4MAOB
SCHEMBL7223524 0.85 CCR5 (0.53) CCR5
SCHEMBL7216092 0.84 CCR5 (0.51) CCR5
SCHEMBL7222239 0.84 CCR5 (0.50) CCR5
SCHEMBL7222254 0.84 CCR5 (0.50) CCR5
SCHEMBL7222236 0.84 CCR5 (0.50) CCR5
SCHEMBL7222250 0.84 CCR5 (0.50) CCR5
SCHEMBL7216646 0.83 CCR5 (0.52) CCR5
SCHEMBL5204993 0.83 CCR5 (0.56) CCR5CHRM4
SCHEMBL7216414 0.81 CCR5 (0.54) CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed